Indonesia’s Health Ministry has indicated that the prices of medications may rise due to the fluctuating exchange rate between the Indonesian Rupiah and the US dollar, coupled with increasing global oil prices. The Ministry acknowledges these external economic factors are creating upward pressure on pharmaceutical costs. While the extent of the price increases remains unclear, officials are monitoring the situation closely. The Ministry has not yet specified which medications will be most affected, or by how much prices could change. This potential increase could impact healthcare accessibility for Indonesian citizens. Further details regarding mitigation strategies or price controls were not immediately available.